Transdermal microemulsions of Boswellia carterii Bird: Formulation, characterization and in vivo evaluation of anti-inflammatory activity

Drug Delivery

Volumn 22, Issue 6, 2015, Pages 748-756

  Mostafa, Dina Mahmoud ^a   Ammar, Nagwa Mohammed ^a   Basha, Mona ^a   Hussein, Rehab Ali ^a   El Awdan, Sally ^a   Awad, Gamal ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Anti inflammatory; boswellic acids; skin irritancy; skin permeation; topical application

Indexed keywords

11 OXO BETA BOSWELLIC ACID; ANTIINFLAMMATORY AGENT; MACROGOL 400; OLEOGUM RESIN; PIROXICAM; PLANT RESIN; POLYSORBATE 80; UNCLASSIFIED DRUG; VEGETABLE OIL; ACETYL-11-KETOBOSWELLIC ACID; ACYLGLYCEROL; CAPMUL MCM C8; EMULSION; LABRASOL; MACROGOL DERIVATIVE; POLYSORBATE; TRITERPENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BOSWELLIA SACRA; CARRAGEENAN-INDUCED PAW EDEMA; CONTROLLED STUDY; DRUG FORMULATION; DRUG PENETRATION; DRUG SCREENING; DRUG SOLUBILITY; ERYTHEMA; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; MICROEMULSION; MICROENCAPSULATION; NONHUMAN; PARTICLE SIZE; PH; PRIORITY JOURNAL; RAT; SKIN IRRITATION; TOXICITY TESTING; ANIMAL; BOSWELLIA; CHEMISTRY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; EMULSION; INTRADERMAL DRUG ADMINISTRATION; MEDICINAL CHEMISTRY; MOUSE; PROCEDURES; SKIN ABSORPTION; TRANSMISSION ELECTRON MICROSCOPY; WISTAR RAT;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS; BOSWELLIA; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; EMULSIONS; FEMALE; GLYCERIDES; HYDROGEN-ION CONCENTRATION; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYSORBATES; RATS; RATS, WISTAR; RESINS, PLANT; SKIN ABSORPTION; SKIN IRRITANCY TESTS; TRITERPENES;

EID: 84941268286     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2014.898347     Document Type: Article

References (49)

1. Ammar HO, Badawi AA, Mostafa DM, Abou-Taleb SA. (2013a). Novel microemulsions as transdermal delivery systems for enhanced efficacy of fluoxetine hydrochloride. AJPSR 2: 1-16
2. Ammar NM, El Hawary SS, Mahdy AA, et al. (2013b). Phyto chemical study of the biologically active fractions of the oleo gum resin of Boswellia carterii and Commiphora myrrha. Advances in Environmental Biology 7: 2573-83
3. Ammon HP. (2006). Boswellic acids in chronic inflammatory diseases. Planta Med 72: 1100-16
4. Araujo LM, Thomazine JA, Lopez RF. (2010). Development of microemulsions to topically deliver 5-aminolevulinic acid in photodynamic therapy. Eur J Pharm Biopharm 75: 48-55
5. Azeem A, Khan ZI, Aqil M, et al. (2009). Microemulsions as a surrogate carrier for dermal drug delivery. Drug Dev Ind Pharm 35: 525-47
6. Banno N, Akihisa T, Yasukawa K, et al. (2006). Anti-inflammatory activities of the triterpene acids from the resin of Boswellia carteri. J Ethnopharmacol 107: 249-53
7. Barthe L, Woodley J, Houin G. (1999). Gastrointestinal absorption of drugs: methods and studies. Fundam Clin Pharmacol 13: 154-68
8. Chaiyana W, Saeio K, Hennink WE, Okonogi S. (2010). Characterization of potent anticholinesterase plant oil based microemulsion. Int J Pharm 401: 32-40
9. Chen H, Chang X, Weng T, et al. (2004). A study of microemulsion systems for transdermal delivery of triptolide. J Control Release 98: 427-36
10. Chessa M, Caddeo C, Valenti D, et al. (2011). Effect of penetration enhancer containing vesicles on the percutaneous delivery of Quercetin through new born pig skin. Pharmaceutics 3: 497-509
11. Date AA, Nagarsenker MS. (2008). Parenteral microemulsions: an overview. Int J Pharm 355: 19-30
12. Djekic L, Primorac M. (2008). The influence of cosurfactants and oils on the formation of pharmaceutical microemulsions based on PEG-8 caprylic/capric glycerides. Int J Pharm 352: 231-9
13. El Maghraby GM. (2008). Transdermal delivery of hydrocortisone from eucalyptus oil microemulsion: effects of cosurfactants. Int J Pharm 355: 285-92
14. El Maghraby GM. (2010). Self-microemulsifying and microemulsion systems for transdermal delivery of indomethacin: effect of phase transition. Colloids Surf B Biointerfaces 75: 595-600
15. Gerbeth K, Husch J, Fricker G, et al. (2013). In vitro metabolism, permeation and brain availability of six major boswellic acids from Boswellia serrata gum resins. Fitoterapia 84: 99-106
16. Gupta I, Gupta V, Parihar A, et al. (1998). Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study. Eur J Med Res 3: 511-14
17. Gupta SK, Bansal P, Bhardwaj RK, et al. (2002). Comparison of analgesic and anti-inflammatory activity of meloxicam gel with diclofenac and piroxicam gels in animal models: pharmacokinetic parameters after topical application. Skin Pharmacol Appl Skin Physiol 15: 105-11
18. Hadgraft J. (2001). Skin, the final frontier. Int J Pharm 224: 1-18
19. Hathout RM, Elshafeey AH. (2012). Development and characterization of colloidal soft nano-carriers for transdermal delivery and bioavailability enhancement of an angiotensin II receptor blocker. Eur J Pharm Biopharm 82: 230-40
20. Hathout RM, Mansour S, Geneidi AS, Mortada ND. (2011). Visualization, dermatopharmacokinetic analysis and monitoring the conformational effects of a microemulsion formulation in the skin stratum corneum. J Colloid Interface Sci 354: 124-30
21. Hathout RM, Woodman TJ, Mansour S, et al. (2010). Microemulsion formulations for the transdermal delivery of testosterone. Eur J Pharm Sci 40: 188-96
22. Heuschkel S, Wohlrab J, Neubert RH. (2009). Dermal and transdermal targeting of dihydroavenanthramide D using enhancer molecules and novel microemulsions. Eur J Pharm Biopharm 72: 552-60
23. Huang YB, Lin YH, Lu TM, et al. (2008). Transdermal delivery of capsaicin derivative-sodium nonivamide acetate using microemulsions as vehicles. Int J Pharm 349: 206-11
24. Husch J, Bohnet J, Fricker G, et al. (2013). Enhanced absorption of boswellic acids by a lecithin delivery form (Phytosome(R)) of Boswellia extract. Fitoterapia 84: 89-98
25. Kawakami K, Yoshikawa T, Moroto Y, et al. (2002). Microemulsion formulation for enhanced absorption of poorly soluble drugs. I Prescription design. J Control Release 81: 65-74
26. Khurana S, Jain NK, Bedi PM. (2013). Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation. Life Sci 92: 383-92
27. Kimmatkar N, Thawani V, Hingorani L, Khiyani R. (2003). Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee:a randomized double blind placebo controlled trial. Phytomedicine 10: 3-7
28. Kogan A, Garti N. (2006). Microemulsions as transdermal drug delivery vehicles. Adv Colloid Interface Sci 123: 369-85
29. Kogan A, Rozner S, Mehta S, et al. (2009). Characterization of the non-ionic microemulsions by EPR. I. Effect of solubilized drug on nanostructure. J Phys Chem B 113: 691-9
30. Kreilgaard M. (2002). Influence of microemulsions on cutaneous drug delivery. Adv Drug Deliv Rev 54: 77-98
31. Lawrence MJ, Rees GD. (2000). Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 45: 89-121
32. Liu CH, Chang FY, Hung DK. (2011). Terpene microemulsions for transdermal curcumin delivery: effects of terpenes and cosurfactants. Colloids Surf B Biointerfaces 82: 63-70
33. Maiti K, Mukherjee K, Gantait A, et al. (2007). Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm 330: 155-63
34. Mandawgade SD, Patravale VB. (2008). Development of SLNs from natural lipids: application to topical delivery of tretinoin. Int J Pharm 363: 132-8
35. Menon MK, Kar A. (1971). Analgesic and psychopharmacological effects of the gum resin of Boswellia serrata. Planta Med 19: 333-41
36. Pakpayat N, Nielloud F, Fortune R, et al. (2009). Formulation of ascorbic acid microemulsions with alkyl polyglycosides. Eur J Pharm Biopharm 72: 444-52
37. Patravale VB, Date AA, Kulkarni RM. (2004). Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol 56: 827-40
38. Poeckel D, Werz O. (2006). Boswellic acids: biological actions and molecular targets. Curr Med Chem 13: 3359-69
39. Roy S, Khanna S, Shah H, et al. (2005). Human genome screen to identify the genetic basis of the anti-inflammatory effects of Boswellia in microvascular endothelial cells. DNA Cell Biol 24: 244-55
40. Singh S, Khajuria A, Taneja SC, et al. (2008). Boswellic acids: a leukotriene inhibitor also effective through topical application in inflammatory disorders. Phytomedicine 15: 400-7
41. Tavano L, Alfano P, Muzzalupo R, De Cindio B. (2011). Niosomes vs microemulsions: new carriers for topical delivery of Capsaicin. Colloids Surf B Biointerfaces 87: 333-9
42. Tenjarla S. (1999). Microemulsions: an overview and pharmaceutical applications. Crit Rev Ther Drug Carrier Syst 16: 461-521
43. Wang Y, Sun Y, Wang C, et al. (2013). Biotransformation of 11-keto-beta-boswellic acid by Cunninghamella blakesleana. Phytochemistry 96: 330-6
44. Wildfeuer A, Neu IS, Safayhi H, et al. (1998). Effects of boswellic acids extracted from a herbal medicine on the biosynthesis of leukotrienes and the course of experimental autoimmune encephalomyelitis. Arzneimittelforschung 48: 668-74
45. Woolley CL, Suhail MM, Smith BL, et al. (2012). Chemical differentiation of Boswellia sacra and Boswellia carterii essential oils by gas chromatography and chiral gas chromatography-mass spectrometry. J Chromatogr A 1261: 158-63
46. Yuan JS, Yip A, Nguyen N, et al. (2010). Effect of surfactant concentration on transdermal lidocaine delivery with linker microemulsions. Int J Pharm 392: 274-84
47. Yuan Y, Cui SX, Wang Y, et al. (2013). Acetyl-11-keto-beta-boswellic acid (AKBA) prevents human colonic adenocarcinoma growth through modulation of multiple signaling pathways. Biochim Biophys Acta 1830: 4907-16
48. Zhang J, Michniak-Kohn B. (2011). Investigation of microemulsion microstructures and their relationship to transdermal permeation of model drugs: ketoprofen, lidocaine and caffeine. Int J Pharm 421: 34-44
49. Zhao X, Liu JP, Zhang X, Li Y. (2006). Enhancement of transdermal delivery of theophylline using microemulsion vehicle. Int J Pharm 327: 58-64